ArticleCureus2025
Prolonged Length of Stay After One- and Two-Level Transforaminal Lumbar Interbody Fusion (TLIF): Risk Factors and Consequent Outcomes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
of background dataWhile many studies have assessed factors associated with prolonged length of stay (LOS) following spine surgery, a limited number of studies have large cohorts with granular individual patient-level data, and little is known about the association between prolonged LOS and functional recovery after spine surgery.
objectiveWe aim to identify factors associated with prolonged length of stay (LOS) and its impact on postoperative complications and functional recovery.
methodsThe present study is a retrospective longitudinal observational cohort study. Patients (N=576) who underwent one- or two-level transforaminal lumbar interbody fusion (TLIF) were identified. LOS was measured in hours, and prolonged LOS was defined as greater than the 75th percentile (>85 hours). Demographic and surgical parameters, and in-hospital and post-discharge complications were collected. Patient-reported outcome measures (PROMs), including the Oswestry Disability Index (ODI) and Numeric Rating Scale (NRS) scores for back and leg pain, were collected preoperatively and at six weeks, three months, and one year postoperatively. Multiple logistic regression identified factors associated with prolonged LOS and post-discharge complications.
resultsThe mean LOS for the entire cohort was 75.0±50.1 hours, with 145 patients categorized as prolonged LOS (141.4±54.5 hours). Prolonged LOS was independently associated with older age (odds ratio (OR)=1.03, p=0.003), lower preoperative hemoglobin (OR=0.80, p=0.020), longer operative time (OR=1.01, p<0.001), and in-hospital complications (OR=11.09, p<0.001). Prolonged LOS was also associated with higher post-discharge complication rates, including 30-day readmission (14% versus 6%, p=0.004), surgical site infection (6% versus 1%, p=0.002), and deep vein thrombosis (DVT)/pulmonary embolism (PE) (3% versus 0%, p=0.001). As complications are known to prolong LOS, a sub-analysis of 205 patients with complete PROMs and no post-discharge complications was performed. In this sub-analysis, patients with prolonged LOS had significantly worse preoperative ODI (51.8 versus 48.5, p=0.025), back pain (7.1 versus 6.2, p=0.013), and leg pain (6.8 versus 5.9, p=0.035). Postoperatively, improvement in PROMs was worse in prolonged LOS patients at all time points.
conclusionProlonged LOS after one- or two-level TLIF was associated with older age, lower preoperative hemoglobin, longer operative time, and in-hospital complications. It was also associated with a higher risk of post-discharge complications and lower functional status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.